Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Monday. $61.80 million flowed into the stock on the tick-up and $145.95 million flowed out of the stock on the tick-down, for a money net flow of $84.15 million out of the stock. Of all stocks tracked, Johnson & Johnson had the 5th highest net out-flow for the day. Johnson & Johnson traded up $0.23 for the day and closed at $133.45
Several analysts have commented on the stock. Zacks Investment Research cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research note on Friday, July 21st. Atlantic Securities cut shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating and set a $113.00 target price for the company. in a research note on Friday, July 21st. BTIG Research cut shares of Johnson & Johnson from a “neutral” rating to a “sell” rating and set a $110.00 target price for the company. in a research note on Friday, July 21st. Alembic Global Advisors cut shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating in a research note on Friday, July 21st. Finally, Vetr cut shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 target price for the company. in a research note on Monday, September 18th. Five equities research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $135.45.
The firm has a market cap of $358.18 billion, a price-to-earnings ratio of 22.58 and a beta of 0.78. The firm’s 50-day moving average is $132.23 and its 200-day moving average is $129.87.
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. Johnson & Johnson had a net margin of 22.52% and a return on equity of 26.76%. The firm had revenue of $18.84 billion during the quarter, compared to the consensus estimate of $18.94 billion. During the same period in the prior year, the firm earned $1.74 EPS. The business’s revenue was up 1.9% on a year-over-year basis. Equities research analysts forecast that Johnson & Johnson will post $7.18 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th were issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend was Friday, August 25th. Johnson & Johnson’s dividend payout ratio (DPR) is presently 56.76%.
In other Johnson & Johnson news, VP Paulus Stoffels sold 102,692 shares of the stock in a transaction on Monday, July 24th. The shares were sold at an average price of $133.14, for a total value of $13,672,412.88. Following the completion of the sale, the vice president now directly owns 230,342 shares of the company’s stock, valued at approximately $30,667,733.88. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Dominic J. Caruso sold 82,591 shares of the stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $136.72, for a total transaction of $11,291,841.52. Following the completion of the sale, the vice president now directly owns 226,693 shares of the company’s stock, valued at $30,993,466.96. The disclosure for this sale can be found here. 0.19% of the stock is owned by corporate insiders.
A number of institutional investors have recently modified their holdings of the business. Amarillo National Bank boosted its holdings in Johnson & Johnson by 7.3% in the 3rd quarter. Amarillo National Bank now owns 6,071 shares of the company’s stock valued at $789,000 after purchasing an additional 411 shares during the period. First National Bank of Mount Dora Trust Investment Services boosted its holdings in Johnson & Johnson by 2.6% in the 3rd quarter. First National Bank of Mount Dora Trust Investment Services now owns 53,176 shares of the company’s stock valued at $6,914,000 after purchasing an additional 1,350 shares during the period. Curbstone Financial Management Corp boosted its holdings in Johnson & Johnson by 99.1% in the 3rd quarter. Curbstone Financial Management Corp now owns 30,400 shares of the company’s stock valued at $3,952,000 after purchasing an additional 15,134 shares during the period. Bogart Wealth LLC boosted its holdings in Johnson & Johnson by 6.7% in the 2nd quarter. Bogart Wealth LLC now owns 6,006 shares of the company’s stock valued at $795,000 after purchasing an additional 378 shares during the period. Finally, MPS Loria Financial Planners LLC bought a new stake in Johnson & Johnson in the 2nd quarter valued at $1,415,000. 65.90% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Traders Sell Johnson & Johnson (JNJ) on Strength (JNJ)” was published by BBNS and is the property of of BBNS. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/traders-sell-johnson-johnson-jnj-on-strength-jnj/1702803.html.
Johnson & Johnson Company Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with our FREE daily email newsletter.